AGRX


William Tanner Cuts Price Target on Agile Therapeutics Inc (AGRX) But Believes Twirla Patch “Still Approvable”

Even though Cantor’s William Tanner slices his price target, he nonetheless angles for almost 115% whopping upside potential for AGRX shares.

FBR Weighs in on Volatile Stocks: Kite Pharma Inc (KITE) and Agile Therapeutics Inc (AGRX)

The biotech-verse was buzzing this week after Kite Pharma Inc (NASDAQ:KITE) submitted an IND application for its pipeline cancer drug that sent shares rising. …

Here’s Why Agile Therapeutics Inc (AGRX) Shares Are Crashing 49% Today; Cantor Remains Bullish

Agile Therapeutics Inc (NASDAQ:AGRX) investors are in a scramble today after the firm released top-line data from its SECURE Phase 3 study of …

Wednesday’s Mid-Day Movers: Sunedison Inc (SUNE), Agile Therapeutics Inc (AGRX), Kura Oncology Inc (KURA)

Sunedison Inc (NYSE:SUNE) is up over 4% in mid-day trading following the company’s announcement that it would extinguish $336 million in debt. In …

We Continue To Believe That Shares Of Agile Hold A Strong Risk/Reward Profile, Says William Blair

In a research report released today, William Blair analyst Tim Lugo reaffirmed an Outperform rating on Agile Therapeutics (NASDAQ:AGRX) with an $18 price …

Janney Capital Reiterates Buy On Agile Therapeutics Following Initiation Of Phase III Twirla Study

In a research note released today, Janney Capital analyst Kimberly Lee reiterated a Buy rating on Agile Therapeutics (NASDAQ:AGRX) with an $18 fair value …

Agile Initiated With A Buy At Janney Capital; Considers AGRX A Compelling Investment

Janney Capital analyst Kimberly Lee is out today with an interesting call initiating Agile Therapeutics, Inc. (AGRX) with a Buy rating and $18 fair …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts